Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...
On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...
Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...
According to Coherent Market Insights, the global cardiac pacemaker market is estimated to be valued at USD 4,907.2 million in 2024 and is expected to surpass USD 6,838.6 million by 2031, growing at a ...
A pacemaker is a small, battery-powered device implanted in your chest to help regulate your heart rate. It consists of two main parts—a pulse generator and leads. Pulse generator: This contains the ...
“Use of these data therefore not only spreads disinformation but also helps the political project of scientific racism—the misuse of science to promote the idea that racial hierarchies and ...
The HeartLogic algorithm then combines these into 1 composite index that indicates decompensation. Boston Scientific's HeartLogic and Latitude NXT Patient Management System work together to provide ...